Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yueying Gu

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Chinese Medical Journal|June 5, 2003
Transfection, overexpression and clinical application of human 60 kDa Ro/SSA autoantigens in HEp-2 cellsLiangjing Lu, Shunle Chen, Yueying Gu, et al.
Chinese Medical Journal|August 26, 2003
Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trialChunde Bao, Shunle Chen, Yueying Gu, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Chinese Medical Journal|June 5, 2003
Transfection, overexpression and clinical application of human 60 kDa Ro/SSA autoantigens in HEp-2 cellsLiangjing Lu, Shunle Chen, Yueying Gu, et al.
Chinese Medical Journal|August 26, 2003
Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trialChunde Bao, Shunle Chen, Yueying Gu, et al.
Pageof 2